3 studies found for:    19249633 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment
Conditions: Myocardial Infarction;   STEMI
Intervention: Genetic: CYP2C19 genotyping
2 Unknown  Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
Conditions: ST-Elevation Myocardial Infarction;   Primary Percutaneous Coronary Intervention
Interventions: Drug: prasugrel/bivalirudin;   Drug: clopidogrel/abciximab
3 Completed
Has Results
A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention
Conditions: Coronary Arteriosclerosis;   Acute Coronary Syndromes
Interventions: Drug: Prasugrel;   Drug: Clopidogrel

Indicates status has not been verified in more than two years